Connect with us


Pakistan Prime Minister Imran Khan tests positive for COVID | Coronavirus pandemic News



The 68-year-old Pakistani premier is self-isolating after contracting COVID-19 two days after being vaccinated.

Pakistan’s Prime Minister Imran Khan has tested positive for COVID-19, his office said, just two days after he was vaccinated against the disease.

“At this point, the prime minister’s office can only confirm that the honourable prime minister has tested positive for COVID-19 and has self-isolated, we will release more details in due course,” his office said on Saturday.

Khan, 68, received a shot of the Chinese-produced Sinopharm vaccine on Thursday, as the country battles a third wave of the virus.

Khan has been holding regular and frequent meetings lately, including attending a security conference held in the capital, Islamabad, that was attended by a large number of people.

He addressed the conference without wearing a mask, and attended another gathering to inaugurate a housing project for poor people in a similar fashion on Friday.

The South Asian nation of 220 million is seeing a sharp rise in coronavirus infections.

According to numbers released by government on Saturday, 3,876 people tested positive in the last 24 hours  – the highest number of daily infections since early July – taking the total number of infections in the country past 620,000.

There were also 42 more deaths, taking the total to 13,799.

Pakistan launched vaccinations for the general public on March 10, starting with elderly people after seeing a poor response from front-line health workers, who expressed concerns about Chinese vaccines.

Chinese Sinopharm and CanSinoBIO, Oxford-AstraZeneca, and Russia’s Sputnik V vaccines have been approved for emergency use in Pakistan.


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertise With Us

To make Advert inquiries or place an order, please contact us at [email protected] or 08073063036 and we’ll reply to you with our Ad rates and other necessary information.